logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
T

Toshifumi Tada

kobe university

54H指数
455论文数
1.3W被引数
收录论文 232
发表时间
logo
Response to the Letter Regarding “Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial”对“Durvalumab联合Tremelimumab治疗符合或不符合HIMALAYA III期试验入组标准的肝细胞癌患者真实世界临床实践结果”一文的读者来信的回复
errJournal of Gastroenterology and Hepatology
IF3.4
err2026-09-07
err0
PREAI
errToshifumi Tada; Tomomitsu Matono; Takashi Kumada
err分享
err收藏
Response to the Letter Regarding “Methodological Considerations in Real-World Evaluation of Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma”对“关于不可切除肝细胞癌中 durvalumab 联合 tremelimumab 现实世界评估的方法学考量”一文的回复
errJournal of Gastroenterology and Hepatology
IF3.4
err2026-09-07
err0
PREAI
errToshifumi Tada; Tomomitsu Matono; Takashi Kumada; the RELPEC Group
err分享
err收藏
Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma在初始使用阿替利珠单抗/贝伐珠单抗控制疾病后，疾病进展时基于消融的挽救策略在肝细胞癌中的应用
errHepatology Research
IF3.4
err2026-05-11
err0
PREAI
errKazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Fujimasa Tada; Hideko Ohama; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Kazunari Tanaka; Kunihiko Tsuji; Ei Itobayashi; Akemi Tsutsui; Koichi Takaguchi; Michitaka Imai; Toru Ishikawa; Takeshi Hatanaka; Yuki Kanayama; Satoru Kakizaki; Atsushi Naganuma; Yoshihide Ueda; Tomomitsu Matono; Hideyuki Tamai; Junpei Okamura; Hironori Tanaka; Yutaka Yata; Akiko Wakuta; Masatoshi Kudo; Takashi Kumada
err分享
err收藏
Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score-Matched Study Using Linear Mixed-Effects Models与恩替卡韦相比，替诺福韦艾拉酚胺在降低乙型肝炎表面抗原方面的卓越疗效：一项使用线性混合效应模型的多中心倾向性评分匹配研究
errALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
err2026-05-04
err0
PREAI
errTakashi Kumada; Masanori Atsukawa; Norio Itokawa; Taeang Arai; Hidenori Toyoda; Akihito Tsubota; Tsunamasa Watanabe; Makoto Chuma; Kentaro Matsuura; Atsushi Hiraoka; Toshifumi Tada; Koichi Takaguchi; Keizo Kato; Hiroshi Abe; Joji Tani; Toru Ishikawa; Chikara Ogawa; Toru Asano; Tsunekazu Oikawa; Yoshihiro Matsumoto; Tomoyuki Akita; Junko Tanaka
err分享
err收藏
Diagnostic Impact of Two-Dimensional Shear Wave Elastography for Liver Fibrosis: A Multicenter Retrospective Study二维剪切波弹性成像对肝纤维化的诊断影响：一项多中心回顾性研究
errHepatology Research
IF3.4
err2026-05-01
err0
errOAAI
errTakashi Nishimura; Toshifumi Tada; Yasuaki Suzuki; Kento Imajo; Katsutoshi Sugimoto; Sadanobu Ogawa; Hidenori Toyoda; Tamami Abe; Hidekatsu Kuroda; Masashi Hirooka; Asako Nogami; Satoshi Oeda; Hirokazu Takahashi; Tomoyuki Akita; Reiichiro Kondo; Takuma Nakatsuka; Ryosuke Tateishi; Yoichi Hiasa; Yuichiro Eguchi; Atsushi Nakajima; Hirohisa Yano; Shigehiro Kokubu; Junko Tanaka; Fuminori Moriyasu; Masayoshi Kage; Takashi Kumada; Hiroko Iijima
err分享
err收藏
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab不可切除性肝细胞癌接受阿替利珠单抗联合贝伐珠单抗治疗后出血事件的临床特征、预测因素及抗血栓治疗的影响
errHepatology Research
IF3.4
err2026-04-21
err0
PREAI
errFujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group
err分享
err收藏
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab肝内肿瘤负荷对接受阿替利珠单抗联合贝伐珠单抗治疗的合并肝外转移的肝细胞癌患者预后的影响
errHepatology Research
IF3.4
err2026-04-10
err0
PREAI
errKazunari Tanaka; Kunihiko Tsuji; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Fujimasa Tada; Hideko Ohama; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
err分享
err收藏
Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus Infection接受丙型肝炎病毒感染持续病毒学应答后发展为肝细胞癌患者的肝纤维化变化
errJournal of Medical Virology
IF4.6
err2026-03-06
err0
PREAI
errHidenori Toyoda; Akito Nozaki; Atsushi Hiraoka; Ei Itobayashi; Haruki Uojima; Hiroshi Abe; Koichi Takaguchi; Masanori Atsukawa; Norio Itokawa; Kentaro Matsuura; Motoyuki Kojima; Toru Ishikawa; Tsunamasa Watanabe; Shigeru Mikami; Kunihiko Tsuji; Hideko Ohama; Fujimasa Tada; Akemi Tsutsui; Tomomi Okubo; Taeang Arai; Makoto Nakamuta; Michitaka Imai; Kazunari Tanaka; Toshifumi Tada; Shinichiro Nakamura; Noritomo Shimada; Takashi Kumada
err分享
err收藏
Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab淋巴细胞-单核细胞比值预测接受度鲁单单抗联合曲美单抗治疗的HCC患者的生存情况
errLiver International
IF5.2
err2026-02-26
err0
PREAI
errTomomitsu Matono; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Shinya Fukunishi; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the RELPEC Group and HCC 48 Group
err分享
err收藏
Response to ‘Letter to the Editor: “Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis”’对‘致编辑信：“淋巴细胞-单核细胞比值预测接受度鲁单抗联合曲美单抗治疗不可切除肝细胞癌患者的生存：一项多中心分析”’的回复
errHepatology Research
IF3.4
err2026-02-25
err0
PREAI
errTatsuya Sakane; Toshifumi Tada; Takanori Matsuura
err分享
err收藏
Prognostic Value of an Early Response to Tolvaptan and Its Clinical Implications in Patients With Cirrhosis and Hepatic Edema: A Nationwide Multicenter Cohort Study托伐普坦早期反应的预后价值及其在肝硬化伴肝性水肿患者中的临床意义：一项全国多中心队列研究
errHepatology Research
IF3.4
err2026-02-07
err0
errOAAI
errKaori Koyano; Taeang Arai; Hidenori Toyoda; Keizo Kato; Joji Tani; Suguru Ogura; Tomomi Okubo; Korenobu Hayama; Norio Itokawa; Toshifumi Tada; Akito Nozaki; Atsushi Hiraoka; Kentaro Matsuura; Toru Ishikawa; Naoto Kawabe; Tsunamasa Watanabe; Koichi Takaguchi; Asahiro Morishita; Hironao Okubo; Motoh Iwasa; Hiroki Nishikawa; Yasuhito Tanaka; Masanori Atsukawa
err分享
err收藏
Editorial: Beyond DNA Suppression: HBV RNA as a Predictor of Hepatocarcinogenesis编辑述评：超越DNA抑制：HBV RNA作为肝细胞癌发生的预测指标
errAlimentary Pharmacology & Therapeutics
IF6.7
err2025-12-10
err0
errOAAI
errToshifumi Tada
err分享
err收藏
Impact of intrahepatic lesions on lesion-specific response rates in patients with hepatocellular carcinoma treated with lenvatinib or immune checkpoint inhibitors肝内病灶对接受仑伐替尼或免疫检查点抑制剂治疗的肝细胞癌患者病灶特异性应答率的影响
errHPB
IF2.4
err2025-11-15
err0
PREAI
errMasaki Omori; Shohei Komatsu; Toshifumi Tada; Nobuaki Ishihara; Takanori Matsuura; Eisuke Ueshima; Yoshimi Fujishima; Jun Ishihda; Masahiro Kido; Hidetoshi Gon; Kenji Fukushima; Takeshi Urade; Hiroaki Yanagimoto; Keitaro Sofue; Yuzo Kodama; Takumi Fukumoto
err分享
err收藏
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease日本过去二十年间肝细胞癌治疗结果的演变：早期病毒性疾病的改善
errHEPATOLOGY RESEARCH
IF3.4
err2025-11-01
err0
errOAAI
errKariyama, Kazuya; Nouso, Kazuhiro; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Toyoda, Hidenori; Yasuda, Satoshi; Tada, Toshifumi; Tanaka, Kazunari; Tsuji, Kunihiko; Itobayashi, Ei; Tsutsui, Akemi; Takaguchi, Koichi; Imai, Michitaka; Ishikawa, Toru; Hatanaka, Takeshi; Kakizaki, Satoru; Naganuma, Atsushi; Ueda, Yoshihide; Matono, Tomomitsu; Tamai, Hideyuki; Okamura, Junpei; Tanaka, Hironori; Yata, Yutaka; Wakuta, Akiko; Kudo, Masatoshi; Kumada, Takashi
err分享
err收藏
Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis淋巴细胞-单核细胞比率预测接受度鲁单单抗联合曲美木单抗治疗不可切除性肝细胞癌患者的生存情况：一项多中心分析
errHEPATOLOGY RESEARCH
IF3.4
err2025-11-01
err1
errOAAI
errSakane, Tatsuya; Tada, Toshifumi; Tei, Hiroshi; Kushida, Saeko; Momose, Kenji; Hirano, Hirotaka; Nishioka, Chiharu; Yagi, Yosuke; Yamamoto, Atsushi; Matono, Tomomitsu; Yoshida, Ryutaro; Ueda, Yoshihide; Nishi, Katsuhisa; Kim, Soo Ki; Yasutomi, Eiichiro; Hirohata, Sigeya; Yoon, Seitetsu; Ehara, Mayumi; Kawano, Miki; Tamura, Shoji; Inoue, Yuta; Kitadai, Jun; Matsuura, Takanori; Shiomi, Yuuki; Yano, Yoshihiko; Kodama, Yuzo
err分享
err收藏
Identification of high-risk group for diabetes-associated hepatocellular carcinoma using noninvasive test for liver fibrosis
errEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
IF1.8
err2025-11-01
err0
PREAI
errKariyama, Kazuya; Nouso, Kazuhiro; Hiraoka, Atsushi; Toyoda, Hidenori; Tada, Toshifumi; Tsuji, Kunihiko; Ishikawa, Toru; Hatanaka, Takeshi; Itobayashi, Ei; Takaguchi, Koichi; Tsutsui, Akemi; Naganuma, Atsushi; Yasuda, Satoshi; Kakizaki, Satoru; Tada, Fujimasa; Ohama, Hideko; Wakuta, Akiko; Shiota, Shohei; Kumada, Takashi
err分享
err收藏
Utility of Oncological Resectability Criteria in Recurrent Hepatocellular Carcinoma After Hepatectomy肝切除术后复发性肝细胞癌中肿瘤可切除标准的实用性
errHEPATOLOGY RESEARCH
IF3.4
err2025-11-01
err0
errOAAI
errIshihara, Nobuaki; Komatsu, Shohei; Tada, Toshifumi; Matsuura, Takanori; Ueshima, Eisuke; Sofue, Keitaro; Omori, Masaki; Kido, Masahiro; Gon, Hidetoshi; Fukushima, Kenji; Urade, Takeshi; Tai, Kentaro; Yoshida, Toshihiko; Arai, Keisuke; Yanagimoto, Hiroaki; Kodama, Yuzo; Murakami, Takamichi; Fukumoto, Takumi
err分享
err收藏
Clinical Utility of a Prognostic Scoring System Based on LDH and CRP in HCC Patients Receiving Atezolizumab Plus Bevacizumab基于LDH和CRP的预后评分系统在应用阿替利珠单抗联合贝伐珠单抗治疗的HCC患者中的临床应用价值
errLIVER INTERNATIONAL
IF5.2
err2025-09-19
err0
PREAI
errTanaka, Kazunari; Tsuji, Kunihiko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Ishikawa, Toru; Tajiri, Kazuto; Ohama, Hideko; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Kanayama, Yuki; Tada, Fujimasa; Nakamura, Shinichiro; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Tanaka, Hironori; Noritake, Hidenao; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi
err分享
err收藏
Efficacy and Safety of Durvalumab Plus Tremelimumab in Hepatocellular Carcinoma Patients With Portal Vein Thrombosis and High Tumor Burden: A Multicenter Retrospective Analysis度鲁特玛联合特瑞普利单抗在合并门静脉血栓和高肿瘤负荷的肝细胞癌患者中的有效性与安全性：一项多中心回顾性分析
errHepatology Research
IF3.4
err2025-09-06
err0
PREAI
errHatanaka, Takeshi; Yata, Yutaka; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Kakizaki, Satoru; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Matsui, Kosuke; Naganuma, Atsushi; Tanaka, Hironori; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Ochi, Hironori; Imai, Michitaka; Nakamura, Shinichiro; Komatsu, Shohei; Tamai, Hideyuki; Okamura, Jumpei; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Matsuura, Takanori; Noritake, Hidenao; Enomoto, Hirayuki; Kaibori, Masaki; Fukumoto, Takumi; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi
err分享
err收藏
Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinoma碳离子放射治疗对于肝细胞癌的治疗效果与手术切除相当。
errHepatology Communications
IF4.6
err2025-08-29
err0
errOAAI
errHatanaka, Takeshi; Shibuya, Kei; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Kariyama, Kazuya; Itobayashi, Ei; Tsuji, Kunihiko; Ishikawa, Toru; Toyoda, Hidenori; Koshiyama, Yuichi; Naganuma, Atsushi; Miyasaka, Yuhei; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Nakamura, Shinichiro; Kumada, Takashi; Ohno, Tatsuya; On behalf of the Real-life Practice Experts for HCC (RELPEC) Study Group
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Masatoshi Kudo
H 指数: 143 · 论文数: 2.8K
V
Vincent Wai‐Sun Wong
H 指数: 142 · 论文数: 1.2K
H
Henry Lik‐Yuen Chan
H 指数: 112 · 论文数: 704
T
Thomas Berg
H 指数: 109 · 论文数: 1.6K
F
Fabio Marra
H 指数: 92 · 论文数: 705
查看更多